Next Article in Journal
Selective Alteration of the Left Arcuate Fasciculus in Two Patients Affected by Creatine Transporter Deficiency
Next Article in Special Issue
Prevalence and Correlates of the Concurrence of Autism Spectrum Disorder and Obsessive Compulsive Disorder in Children and Adolescents: A Systematic Review and Meta-Analysis
Previous Article in Journal
Concordance between Wada, Transcranial Magnetic Stimulation, and Magnetoencephalography for Determining Hemispheric Dominance for Language: A Retrospective Study
Previous Article in Special Issue
The Relationship between Childhood Trauma Experiences and Psychotic Vulnerability in Obsessive Compulsive Disorder: An Italian Cross-Sectional Study
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Impact of Benzodiazepines and Illness Duration on Obsessive–Compulsive Disorder during COVID-19 in Italy: Exploring Symptoms’ Evolutionary Benefits

by
Giordano D’Urso
1,*,
Alfonso Magliacano
2,
Marco Manzo
1,
Mattia Vittorio Pomes
1,
Carla Iuliano
3,
Felice Iasevoli
1,
Bernardo Dell’Osso
4,5,6 and
Andrea de Bartolomeis
1
1
Section of Psychiatry, Department of Neuroscience, Reproductive, and Odontostomatological Sciences, University of Naples Federico II, 80131 Naples, Italy
2
IRCCS Fondazione Don Carlo Gnocchi ONLUS, 50143 Florence, Italy
3
School of Cognitive Psychotherapy (SPC), 80100 Naples, Italy
4
Department of Biomedical and Clinical Sciences, University of Milan, 20157 Milan, Italy
5
Department of Psychiatry and Behavioral Sciences, Bipolar Disorders Clinic, Stanford University, Stanford, CA 94305, USA
6
“Aldo Ravelli” Center for Nanotechnology and Neurostimulation, University of Milan, 20122 Milan, Italy
*
Author to whom correspondence should be addressed.
Brain Sci. 2024, 14(4), 338; https://doi.org/10.3390/brainsci14040338
Submission received: 29 February 2024 / Revised: 25 March 2024 / Accepted: 28 March 2024 / Published: 30 March 2024

Abstract

Obsessive–compulsive disorder (OCD) is believed to follow a waxing and waning course, often according to environmental stressors. During the COVID-19 pandemic, pre-existing OCD symptoms were reported to increase and to change from checking to washing behaviors, while new-onset symptoms were predominantly of the hoarding type. In the present study, we followed the evolution of OCD symptoms, anxiety, depression, and insights of illness in forty-six OCD patients throughout the pandemic. Clinical measures were collected at four different time points before and during the COVID-19 pandemic in Italy. Within-subject comparisons were used to compare clinical scale scores across time, and correlations were examined between patients’ baseline characteristics and changes in clinical scores. We found that all clinical measures increased during the first Italian lockdown with respect to the pre-pandemic values. Anxiety decreased during the temporary elimination of restriction provisions, whereas the severity of OCD symptoms and insight returned to pre-pandemic values during the second mandatory lockdown. These results were observed only in two sub-groups of patients: those taking benzodiazepines and those with shorter illness duration. Our findings suggest the need for additional clinical attention to these specific sub-groups of OCD patients in case of particularly distressing circumstances while pointing to a possible adaptive role of their OCD symptoms when the environment requires a higher care of hygiene and an extraordinary supply of essential resources.
Keywords: obsessive–compulsive disorder; COVID-19; biological evolution; benzodiazepines; mental health; anxiety disorders; psychopathology obsessive–compulsive disorder; COVID-19; biological evolution; benzodiazepines; mental health; anxiety disorders; psychopathology

Share and Cite

MDPI and ACS Style

D’Urso, G.; Magliacano, A.; Manzo, M.; Pomes, M.V.; Iuliano, C.; Iasevoli, F.; Dell’Osso, B.; de Bartolomeis, A. Impact of Benzodiazepines and Illness Duration on Obsessive–Compulsive Disorder during COVID-19 in Italy: Exploring Symptoms’ Evolutionary Benefits. Brain Sci. 2024, 14, 338. https://doi.org/10.3390/brainsci14040338

AMA Style

D’Urso G, Magliacano A, Manzo M, Pomes MV, Iuliano C, Iasevoli F, Dell’Osso B, de Bartolomeis A. Impact of Benzodiazepines and Illness Duration on Obsessive–Compulsive Disorder during COVID-19 in Italy: Exploring Symptoms’ Evolutionary Benefits. Brain Sciences. 2024; 14(4):338. https://doi.org/10.3390/brainsci14040338

Chicago/Turabian Style

D’Urso, Giordano, Alfonso Magliacano, Marco Manzo, Mattia Vittorio Pomes, Carla Iuliano, Felice Iasevoli, Bernardo Dell’Osso, and Andrea de Bartolomeis. 2024. "Impact of Benzodiazepines and Illness Duration on Obsessive–Compulsive Disorder during COVID-19 in Italy: Exploring Symptoms’ Evolutionary Benefits" Brain Sciences 14, no. 4: 338. https://doi.org/10.3390/brainsci14040338

APA Style

D’Urso, G., Magliacano, A., Manzo, M., Pomes, M. V., Iuliano, C., Iasevoli, F., Dell’Osso, B., & de Bartolomeis, A. (2024). Impact of Benzodiazepines and Illness Duration on Obsessive–Compulsive Disorder during COVID-19 in Italy: Exploring Symptoms’ Evolutionary Benefits. Brain Sciences, 14(4), 338. https://doi.org/10.3390/brainsci14040338

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop